ProKidney is trading 5.47% up now at $2.02, with no September 4, 2026 company-specific announcement or reliable report directly explaining the move.

  • The latest company release, dated August 10, discussed PROACT 1 enrollment and anticipated pivotal results in the second quarter of 2027, rather than a new catalyst.
  • Broader U.S. markets are lower, so the gain does not clearly track overall market sentiment.